3151
Pick & Pay - Nice - Basic earnings per share 26.72 cents 19.86 cents 34.5
Show Posts
This section allows you to view all posts made by this member. Note that you can only see posts made in areas you currently have access to.
3159
Shares / Re: Today's Outlook
« on: October 10, 2014, 03:10:06 pm »
Well at least my African bank shares did not go down today. :laugh:
3161
Shares / Re: Pulverized Sand Box
« on: October 10, 2014, 09:22:41 am »
NPN - 
10c -
APN - Sold to soon
According to one Wall Street proverb, the time to buy is when there is “blood in the streets.” The proverb has been attributed to financier Bernard Baruch and to industrialist John D. Rockefeller, Sr., but it’s most frequently attributed to Baron Rothschild
10c -
APN - Sold to soon
According to one Wall Street proverb, the time to buy is when there is “blood in the streets.” The proverb has been attributed to financier Bernard Baruch and to industrialist John D. Rockefeller, Sr., but it’s most frequently attributed to Baron Rothschild
3162
Shares / Re: Aspen Pharmacare
« on: October 09, 2014, 03:31:11 pm »
JOHANNESBURG (Reuters) - South Africa generic drugmaker Aspen Pharmacare has teamed up with shareholder GlaxoSmithKline PLC to extend its foothold in Japan, a lucrative market for low-cost medicines, it said on Thursday.
Aspen, Africa's biggest generic drugmaker, would sell a 25 percent stake in a newly established Japanese business to GlaxoSmithKline, which already owns about 12 percent of Aspen.
Under the deal, GlaxoSmithKline would transfer distribution rights of certain products to the new entity, Aspen Japan. GSK would also provide Aspen Japan with a pipeline for a number generic medicines.
Politicians in the world's second-biggest pharmaceutical market are lobbying for more generic drugs to go on sale to bring down the cost of healthcare for a rapidly ageing population.
Shares in Aspen climbed 4.3 percent to 354.51 rand by 1050 GMT, outpacing 1.5 percent gain in the JSE Top-40 index.
Aspen, Africa's biggest generic drugmaker, would sell a 25 percent stake in a newly established Japanese business to GlaxoSmithKline, which already owns about 12 percent of Aspen.
Under the deal, GlaxoSmithKline would transfer distribution rights of certain products to the new entity, Aspen Japan. GSK would also provide Aspen Japan with a pipeline for a number generic medicines.
Politicians in the world's second-biggest pharmaceutical market are lobbying for more generic drugs to go on sale to bring down the cost of healthcare for a rapidly ageing population.
Shares in Aspen climbed 4.3 percent to 354.51 rand by 1050 GMT, outpacing 1.5 percent gain in the JSE Top-40 index.
3164
Shares / Re: Devastating market crash. When ?
« on: October 09, 2014, 10:38:27 am »
CML - Orca's
You guys have got me worried about this 'crash' talk and what is the general opinion? Is it imminent? Or won't it happen?
They are only talking about it, may or may not happen. If anybody can accurately predict what will happen with Markets, Rand, Gold, shares, he will be making money (lots) shorting & buying, not talking about it.
I've got a hefty investment in CML, also in the STXIND so hoping my pension pot is not going down the tubes
U only have this 2 for your pension? How long to go about?
You guys have got me worried about this 'crash' talk and what is the general opinion? Is it imminent? Or won't it happen?
They are only talking about it, may or may not happen. If anybody can accurately predict what will happen with Markets, Rand, Gold, shares, he will be making money (lots) shorting & buying, not talking about it.
I've got a hefty investment in CML, also in the STXIND so hoping my pension pot is not going down the tubes
U only have this 2 for your pension? How long to go about?
